Page last updated: 2024-09-03

cimadronate and Peritoneal Carcinomatosis

cimadronate has been researched along with Peritoneal Carcinomatosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iguchi, H; Ikeda, M; Inoue, K; Kataoka, Y; Matsusue, K; Nishino, Y; Nishiyama, K; Takiguchi, S1

Other Studies

1 other study(ies) available for cimadronate and Peritoneal Carcinomatosis

ArticleYear
The bisphosphonate incadronate inhibits intraperitoneal dissemination in an in vivo pancreatic cancer model.
    Oncology reports, 2012, Volume: 28, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Diphosphonates; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Peritoneal Neoplasms; rho-Associated Kinases; Tumor Burden; Xenograft Model Antitumor Assays

2012